RENX — Renalytix Share News
0.000.00%
- £8.30m
- £8.00m
- $3.00m
Holding(s) in Company
Brief: Renalytix Announces Collaboration With Tempus To Advance Intelligent Risk Assessment In Diabetic Kidney Disease
Tempus AI Inc, collaboration agreement
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: Renalytix Secures Contract For Biomarker Research With Joslin Diabetes Center
Services contract with Joslin and Pharma Partner
Brief: Renalytix PLC Mvp Health Care And Renalytix Partner To Bring Kidney Disease Testing To Local Communities
Brief: Renalytix Partners With MVP Health Care For kidneyintelX.dkd Access
Partnership with MVP Health Care
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company